Exact Mass: 459.0683

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate

C14H21NO14S (459.0683)

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 6-sulfate

C14H21NO14S (459.0683)

Sporidesmin J

C17H18ClN3O6S2 (459.0326)

8-oxo-GDP

C10H15N5O12P2 (459.0192)

A purine ribonucleoside 5-diphosphate that is the 8-oxo derivative of GDP.

4-Methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-glucopyranoside

C18H21NO11S (459.0835)

Analogue A

C23H23Cl2N3O3 (459.1116)

Mivebresib

C22H19F2N3O4S (459.1064)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

adenylo-succinate

C14H14N5O11P (459.0427)

Adenylo-succinate is also known as adenylo-succinic acid. Adenylo-succinate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adenylo-succinate can be found in a number of food items such as broad bean, black huckleberry, chinese broccoli, and pitanga, which makes adenylo-succinate a potential biomarker for the consumption of these food products.

SB 212305

C20H17N3O8S (459.0736)

Antibiotic MI 178-34F18A1

C19H19Cl2NO8 (459.0488)

Pyralomicin 2b

C19H19Cl2NO8 (459.0488)

Lamellarin A4

C25H17NO8 (459.0954)

terbium acetylacetonate

C15H24O6Tb (459.0826)

Benzyl N-N-phenylmethoxycarbonyl-N

C18H16F3N3O6S (459.0712)

(2E,5E)-3-benzyl-2-(4-methoxy phenylimino)-5-(3-methylbenzo[d]thiazol-2(3H)-ylidene)thiazolidin-4-one

C25H21N3O2S2 (459.1075)

trifloxysulfuron-sodium

C14H13F3N5NaO6S (459.0436)

Flurazepam hydrochloride

C21H25Cl3FN3O (459.1047)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

8-hydroxy-7-[(4-sulpho-1-naphthyl)azo]quinoline-5-sulphonic acid

C19H13N3O7S2 (459.0195)

Aluminum triquinolin-8-olate

C27H18AlN3O3 (459.1164)

Ticolubant

C23H19Cl2NO3S (459.0463)

C308 - Immunotherapeutic Agent

8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid

C19H13N3O7S2 (459.0195)

4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide

C25H21N3O2S2 (459.1075)

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-5-oxo-6-thiazolo[3,2-a]pyrimidinecarboxamide

C19H17N5O5S2 (459.0671)

Prinomastat hydrochloride

C18H22ClN3O5S2 (459.0689)

7n-Methyl-8-hydroguanosine-5-diphosphate

C11H19N5O11P2 (459.0556)

(C8-R)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)

(C8-S)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)

Mivebresib

C22H19F2N3O4S (459.1064)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

adenylo-succinate

C14H14N5O11P-4 (459.0427)

N(6)-(1,2-dicarboxyethyl)-AMP

C14H14N5O11P-4 (459.0427)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

wogonin 7-O-beta-D-glucuronate

C22H19O11- (459.0927)

The monocarboxylic acid anion that is the conjugate base of wogonin 7-O-beta-D-glucuronide.

CDP-N-methylethanolamine(1-)

C12H21N4O11P2- (459.0682)

oroxylin A 7-O-beta-D-glucuronate

C22H19O11- (459.0927)

The monocarboxylic acid anion that is the conjugate base of oroxylin A 7-O-beta-D-glucuronide.

5-O-[N-(L-Aspartyl)sulfamoyl]adenosine

C14H17N7O9S-2 (459.0808)

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc

C14H21NO14S (459.0683)

Aspartyl-phosphonate-adenosine

C15H20N6O9P- (459.1029)

(2R,3R,4S)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

5-chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide

C23H23Cl2N3O3 (459.1116)

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(methylazaniumyl)ethyl phosphate

C12H21N4O11P2- (459.0682)

4-(2,6-Difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine

C19H19F2NO6S2 (459.0622)

(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H19N4O5S2+ (459.0797)

5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide

C22H16Cl2FN3O3 (459.0553)

N-[1-[[anilino(sulfanylidene)methyl]amino]-2,2,2-trichloroethyl]-2-(4-ethylphenoxy)acetamide

C19H20Cl3N3O2S (459.0342)

(2E)-3-[5-(4-bromophenyl)furan-2-yl]-2-cyano-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide

C24H18BrN3O2 (459.0582)

4-[(2-Methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester

C21H21N3O7S (459.11)

5-chloro-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-2-benzofurancarboxamide

C21H18ClN3O5S (459.0656)

1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(2-bromophenyl)methylidene]-5-(pyrrolidin-1-ylmethyl)-1H-1,2,3-triazole-4-carbohydrazide

C17H18BrN9O2 (459.0767)

prunetin-5-O-beta-D-glucuronide

C22H19O11- (459.0927)

prunetin-4-O-beta-D-glucuronide

C22H19O11- (459.0927)

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S

C14H21NO14S (459.0683)

(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

Farnesyl triphosphate(3-)

C15H26O10P3-3 (459.0739)

2-(Acetylamino)-2-Deoxy-3-O-(4-Deoxy-Alpha-L-Threo-Hex-4-Enopyranuronosyl)-4-O-Sulfo-Beta-D-Galactopyranose

C14H21NO14S (459.0683)

[5-(2-Amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methylperoxy phosphono hydrogen phosphate

C10H15N5O12P2 (459.0192)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-6-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)

7-methyl-7,8-dihydroguanosine-5-diphosphate

C11H19N5O11P2 (459.0556)

A purine ribonucleoside 5-diphosphate having 7-methyl-7,8-dihydroguanine as the nucleobase.

N(6)-(1,2-dicarboxylatoethyl)-AMP(4-)

C14H14N5O11P (459.0427)

Tetraanion of N(6)-(1,2-dicarboxyethyl)-AMP arising from deprotonation of carboxylic acid and phosphate functions.

KG5

C20H16F3N7OS (459.1089)

KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor. KG5 also inhibits Flt3, KIT and c-Raf. KG5 has anticancer, antiangiogenic activities[1].

(4r,5s,6r)-4,5-dihydroxy-6-[(s)-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-5,7,9,12,14,16,18,20-octaen-3-one

C25H17NO8 (459.0954)

2,8-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)

(4s,5s,6s)-4,5-dihydroxy-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)

2,6-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)

8-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C20H17N3O8S (459.0736)

8-{[(2s)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C20H17N3O8S (459.0736)

2,6-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)

(2r,3s,5s,6s)-6-{[(3s,3ar)-7-chloro-5-(cyanomethyl)-3-hydroxy-3h-cyclopenta[a]inden-3a-yl]oxy}-5-hydroxy-2,3-dimethyl-4-oxooxan-3-yl acetate

C23H22ClNO7 (459.1085)

2,8-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)

2-{[9-(4-methylphenyl)-6-oxo-6,9-dihydro-1H-purin-8-yl]sulfanyl}-N-[2-(trifluoromethyl)phenyl]acetamide

C21H16F3N5O2S (459.0977)

2-{[9-(4-methylphenyl)-6-oxo-6,9-dihydro-1H-purin-8-yl]sulfanyl}-N-[3-(trifluoromethyl)phenyl]acetamide

C21H16F3N5O2S (459.0977)

1-{2-[(4-bromo-2-fluorophenyl)amino]-2-oxoethyl}-2-oxo-N-propyl-1,2-dihydroquinoline-4-carboxamide

C21H19BrFN3O3 (459.0594)